| 专利名称 | TLR4 COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS OR FORMULATIONS, METHODS OF PREPARATION, TREATMENT OR USES | ||
| 申请号 | WOEP19067513 | 申请日 | |
| 公开（公告）号 | WO2020007760A1 | 公开（公告）日 | |
| 申请（专利权）人 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED | 发明人 | BHATTACHARYA Sabyasachi; DALWADI Gautam; SATHE Rajendra S; SHUKLA Rahul Parashar; ZHOU Haoyan |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
The present invention relates to novel pharmaceutically acceptable salts of TLR4 agonist compounds and forms thereof, corresponding pharmaceutical compositions or formulations, processes or methods of compound preparation and uses or treatment methods for cancers, which includes associated cancer immunotherapies (i.e., also known as immuno-oncology). |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
